gimli
APLLTD stock analysis context
ALEMBIC PHARMA Stock Context for AI Screening
ALEMBIC PHARMA LTD is a mid-cap stock in Healthcare. This page summarizes key screening signals for ALEMBIC PHARMA, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about APLLTDPrice
₹755.70
1M return
-1.16%
3M return
-0.96%
Market cap
₹14,854.28 cr
PE
25.49
ROE
+11.64%
RSI
50.26
Turnover
₹14.56 cr
Why it can matter in screens
- Momentum: APLLTD is above 50DMA; RSI is 50.26.
- Returns: 1M -1.16%, 3M -0.96%, 6M -16.13%.
- Liquidity: latest turnover is ₹14.56 cr.
- Valuation: PE 25.49, PB n/a, ROE +11.64%, ROCE +13.84%.
- Growth: 3Y sales CAGR +7.72%, 3Y profit CAGR +3.85%.
Try these prompts
- Analyze ALEMBIC PHARMA with valuation, momentum and industry peers
- Compare APLLTD with other Healthcare stocks
- Show mid-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View mid-cap stocks
- Find stocks above 50DMA
- Compare APLLTD with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.